RIPK1 S213E突变通过防止与RIPK3和CASP8相互作用来抑制RIPK1依赖的细胞死亡
Ning Nan1,2,3, Hong Hu4,5,6, Xinxin Zhu4,5,6
1School of Life Science and Technology, ShanghaiTech University, Shanghai, China. nanning@shanghaitech.edu.cn.
Cell death discovery
|July 27, 2025
概括
受体相互作用的氨酸/氨酸蛋白激酶1 (RIPK1),S213E的新型突变抑制了其功能,而不影响激酶活性. 这种突变破坏了RIPK1的功能.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 受体相互作用的氨酸/氨酸蛋白激酶1 (RIPK1) 是细胞增殖,编程细胞死亡 (细胞亡) 和炎症的关键调节者.
- RIPK1的激酶活性在瘤亡因子 (TNF) 信号通路中至关重要,决定细胞命运的决定.
- 影响RIPK1激酶活性的突变对细胞命运和疾病有深远的影响.
研究的目的:
- 为了生成和描述人类RIPK1的新型突变,指定S213E.
- 研究S213E突变对RIPK1活动和下游信号的功能影响.
- 阐明S213E影响RIPK1在亡和亡中的作用的机制.
主要方法:
- 用局部导向的突变发生被用来在人类RIPK1.1中产生S213E突变.
- 进行了生物化学测试,以评估RIPK1激酶活性.
- 协同免疫沉和西式涂抹被用于研究RIPK1的同位体化和与下游效应因子 (如RIPK3) 的相互作用.
主要成果:
- 在人类RIPK1.1中成功生成和特征S213E突变.
- 虽然没有直接抑制激酶活性,但S213E突变显著扰乱了RIPK1的同质化.
- S213E突变影响了RIPK1与关键下游信号分子的相互作用,包括RIPK3.
- 这些干扰有效地使RIPK1处于超级自身抑制状态,与apoptotic和necroptotic通路脱离.
结论:
- S213E突变代表了研究RIPK1调节和功能的独特工具.
- 这种突变为RIPK1的支架和相互作用功能提供了新的见解,独立于其激酶活性,控制细胞死亡信号.
- 准RIPK1相互作用为调节炎症和细胞死亡途径提供了潜在的治疗策略.
更多相关视频
08:55Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
10.9K
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
2.4K
相关概念视频
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
